NCT04095858 2023-02-08
CATHY
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Terminated
Clinical Trials
4 trialsNCT01325571 2016-03-09
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis
Astellas Pharma Inc
Phase 3 Completed
NCT00309088 2014-08-25
FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients
Astellas Pharma Inc
Phase 3 Completed
NCT00309101 2009-06-03
An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
Astellas Pharma Inc
Phase 3 Completed